Both histamine H2-receptor antagonists and gastric proton pump inhibitors are now world-widely used as the first choice for the treatment of acid-related diseases.

The global Gastric Antisecretory Drug market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.

The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for Gastric Antisecretory Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Gastric Antisecretory Drug.

Report Scope

The Gastric Antisecretory Drug market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Gastric Antisecretory Drug market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Gastric Antisecretory Drug manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Gastric Antisecretory Drug Market Report

Report Metric	Details
Report Name	Gastric Antisecretory Drug Market
CAGR	5%
Segment by Type	H2-receptor Antagonists Gastric Proton Pump Inhibitors Others
Segment by Application	Dyspepsia Peptic Ulcer Gastroesophageal Reflux Others
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	Bayer, Cadila Pharmaceuticals, AstraZeneca, Jiangsu Aosaikang, Eisai, Pfizer, Altana Pharma, Takeda, NCPC, Luoxin
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Gastric Antisecretory Drug manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Gastric Antisecretory Drug in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Gastric Antisecretory Drug Market report?

Ans: The main players in the Gastric Antisecretory Drug Market are Bayer, Cadila Pharmaceuticals, AstraZeneca, Jiangsu Aosaikang, Eisai, Pfizer, Altana Pharma, Takeda, NCPC, Luoxin

What are the Application segmentation covered in the Gastric Antisecretory Drug Market report?

Ans: The Applications covered in the Gastric Antisecretory Drug Market report are Dyspepsia, Peptic Ulcer, Gastroesophageal Reflux, Others

What are the Type segmentation covered in the Gastric Antisecretory Drug Market report?

Ans: The Types covered in the Gastric Antisecretory Drug Market report are H2-receptor Antagonists, Gastric Proton Pump Inhibitors, Others

1 Gastric Antisecretory Drug Market Overview

1.1 Product Overview and Scope of Gastric Antisecretory Drug

1.2 Gastric Antisecretory Drug Segment by Type

1.2.1 Global Gastric Antisecretory Drug Market Value Comparison by Type (2024-2030)

1.2.2 H2-receptor Antagonists

1.2.3 Gastric Proton Pump Inhibitors

1.2.4 Others

1.3 Gastric Antisecretory Drug Segment by Application

1.3.1 Global Gastric Antisecretory Drug Market Value by Application: (2024-2030)

1.3.2 Dyspepsia

1.3.3 Peptic Ulcer

1.3.4 Gastroesophageal Reflux

1.3.5 Others

1.4 Global Gastric Antisecretory Drug Market Size Estimates and Forecasts

1.4.1 Global Gastric Antisecretory Drug Revenue 2019-2030

1.4.2 Global Gastric Antisecretory Drug Sales 2019-2030

1.4.3 Global Gastric Antisecretory Drug Market Average Price (2019-2030)

1.5 Assumptions and Limitations

2 Gastric Antisecretory Drug Market Competition by Manufacturers

2.1 Global Gastric Antisecretory Drug Sales Market Share by Manufacturers (2019-2024)

2.2 Global Gastric Antisecretory Drug Revenue Market Share by Manufacturers (2019-2024)

2.3 Global Gastric Antisecretory Drug Average Price by Manufacturers (2019-2024)

2.4 Global Gastric Antisecretory Drug Industry Ranking 2022 VS 2023 VS 2024

2.5 Global Key Manufacturers of Gastric Antisecretory Drug, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of Gastric Antisecretory Drug, Product Type & Application

2.7 Gastric Antisecretory Drug Market Competitive Situation and Trends

2.7.1 Gastric Antisecretory Drug Market Concentration Rate

2.7.2 The Global Top 5 and Top 10 Largest Gastric Antisecretory Drug Players Market Share by Revenue

2.7.3 Global Gastric Antisecretory Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

2.8 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Gastric Antisecretory Drug Retrospective Market Scenario by Region

3.1 Global Gastric Antisecretory Drug Market Size by Region: 2019 Versus 2023 Versus 2030

3.2 Global Gastric Antisecretory Drug Global Gastric Antisecretory Drug Sales by Region: 2019-2030

3.2.1 Global Gastric Antisecretory Drug Sales by Region: 2019-2024

3.2.2 Global Gastric Antisecretory Drug Sales by Region: 2025-2030

3.3 Global Gastric Antisecretory Drug Global Gastric Antisecretory Drug Revenue by Region: 2019-2030

3.3.1 Global Gastric Antisecretory Drug Revenue by Region: 2019-2024

3.3.2 Global Gastric Antisecretory Drug Revenue by Region: 2025-2030

3.4 North America Gastric Antisecretory Drug Market Facts & Figures by Country

3.4.1 North America Gastric Antisecretory Drug Market Size by Country: 2019 VS 2023 VS 2030

3.4.2 North America Gastric Antisecretory Drug Sales by Country (2019-2030)

3.4.3 North America Gastric Antisecretory Drug Revenue by Country (2019-2030)

3.4.4 U.S.

3.4.5 Canada

3.5 Europe Gastric Antisecretory Drug Market Facts & Figures by Country

3.5.1 Europe Gastric Antisecretory Drug Market Size by Country: 2019 VS 2023 VS 2030

3.5.2 Europe Gastric Antisecretory Drug Sales by Country (2019-2030)

3.5.3 Europe Gastric Antisecretory Drug Revenue by Country (2019-2030)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Gastric Antisecretory Drug Market Facts & Figures by Country

3.6.1 Asia Pacific Gastric Antisecretory Drug Market Size by Country: 2019 VS 2023 VS 2030

3.6.2 Asia Pacific Gastric Antisecretory Drug Sales by Country (2019-2030)

3.6.3 Asia Pacific Gastric Antisecretory Drug Revenue by Country (2019-2030)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 Taiwan

3.6.10 Indonesia

3.6.11 Thailand

3.6.12 Malaysia

3.6.13 Philippines

3.7 Latin America Gastric Antisecretory Drug Market Facts & Figures by Country

3.7.1 Latin America Gastric Antisecretory Drug Market Size by Country: 2019 VS 2023 VS 2030

3.7.2 Latin America Gastric Antisecretory Drug Sales by Country (2019-2030)

3.7.3 Latin America Gastric Antisecretory Drug Revenue by Country (2019-2030)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.8 Middle East and Africa Gastric Antisecretory Drug Market Facts & Figures by Country

3.8.1 Middle East and Africa Gastric Antisecretory Drug Market Size by Country: 2019 VS 2023 VS 2030

3.8.2 Middle East and Africa Gastric Antisecretory Drug Sales by Country (2019-2030)

3.8.3 Middle East and Africa Gastric Antisecretory Drug Revenue by Country (2019-2030)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 UAE

4 Segment by Type

4.1 Global Gastric Antisecretory Drug Sales by Type (2019-2030)

4.1.1 Global Gastric Antisecretory Drug Sales by Type (2019-2024)

4.1.2 Global Gastric Antisecretory Drug Sales by Type (2025-2030)

4.1.3 Global Gastric Antisecretory Drug Sales Market Share by Type (2019-2030)

4.2 Global Gastric Antisecretory Drug Revenue by Type (2019-2030)

4.2.1 Global Gastric Antisecretory Drug Revenue by Type (2019-2024)

4.2.2 Global Gastric Antisecretory Drug Revenue by Type (2025-2030)

4.2.3 Global Gastric Antisecretory Drug Revenue Market Share by Type (2019-2030)

4.3 Global Gastric Antisecretory Drug Price by Type (2019-2030)

5 Segment by Application

5.1 Global Gastric Antisecretory Drug Sales by Application (2019-2030)

5.1.1 Global Gastric Antisecretory Drug Sales by Application (2019-2024)

5.1.2 Global Gastric Antisecretory Drug Sales by Application (2025-2030)

5.1.3 Global Gastric Antisecretory Drug Sales Market Share by Application (2019-2030)

5.2 Global Gastric Antisecretory Drug Revenue by Application (2019-2030)

5.2.1 Global Gastric Antisecretory Drug Revenue by Application (2019-2024)

5.2.2 Global Gastric Antisecretory Drug Revenue by Application (2025-2030)

5.2.3 Global Gastric Antisecretory Drug Revenue Market Share by Application (2019-2030)

5.3 Global Gastric Antisecretory Drug Price by Application (2019-2030)

6 Key Companies Profiled

6.1 Bayer

6.1.1 Bayer Corporation Information

6.1.2 Bayer Description and Business Overview

6.1.3 Bayer Gastric Antisecretory Drug Sales, Revenue and Gross Margin (2019-2024)

6.1.4 Bayer Gastric Antisecretory Drug Product Portfolio

6.1.5 Bayer Recent Developments/Updates

6.2 Cadila Pharmaceuticals

6.2.1 Cadila Pharmaceuticals Corporation Information

6.2.2 Cadila Pharmaceuticals Description and Business Overview

6.2.3 Cadila Pharmaceuticals Gastric Antisecretory Drug Sales, Revenue and Gross Margin (2019-2024)

6.2.4 Cadila Pharmaceuticals Gastric Antisecretory Drug Product Portfolio

6.2.5 Cadila Pharmaceuticals Recent Developments/Updates

6.3 AstraZeneca

6.3.1 AstraZeneca Corporation Information

6.3.2 AstraZeneca Description and Business Overview

6.3.3 AstraZeneca Gastric Antisecretory Drug Sales, Revenue and Gross Margin (2019-2024)

6.3.4 AstraZeneca Gastric Antisecretory Drug Product Portfolio

6.3.5 AstraZeneca Recent Developments/Updates

6.4 Jiangsu Aosaikang

6.4.1 Jiangsu Aosaikang Corporation Information

6.4.2 Jiangsu Aosaikang Description and Business Overview

6.4.3 Jiangsu Aosaikang Gastric Antisecretory Drug Sales, Revenue and Gross Margin (2019-2024)

6.4.4 Jiangsu Aosaikang Gastric Antisecretory Drug Product Portfolio

6.4.5 Jiangsu Aosaikang Recent Developments/Updates

6.5 Eisai

6.5.1 Eisai Corporation Information

6.5.2 Eisai Description and Business Overview

6.5.3 Eisai Gastric Antisecretory Drug Sales, Revenue and Gross Margin (2019-2024)

6.5.4 Eisai Gastric Antisecretory Drug Product Portfolio

6.5.5 Eisai Recent Developments/Updates

6.6 Pfizer

6.6.1 Pfizer Corporation Information

6.6.2 Pfizer Description and Business Overview

6.6.3 Pfizer Gastric Antisecretory Drug Sales, Revenue and Gross Margin (2019-2024)

6.6.4 Pfizer Gastric Antisecretory Drug Product Portfolio

6.6.5 Pfizer Recent Developments/Updates

6.7 Altana Pharma

6.6.1 Altana Pharma Corporation Information

6.6.2 Altana Pharma Description and Business Overview

6.6.3 Altana Pharma Gastric Antisecretory Drug Sales, Revenue and Gross Margin (2019-2024)

6.4.4 Altana Pharma Gastric Antisecretory Drug Product Portfolio

6.7.5 Altana Pharma Recent Developments/Updates

6.8 Takeda

6.8.1 Takeda Corporation Information

6.8.2 Takeda Description and Business Overview

6.8.3 Takeda Gastric Antisecretory Drug Sales, Revenue and Gross Margin (2019-2024)

6.8.4 Takeda Gastric Antisecretory Drug Product Portfolio

6.8.5 Takeda Recent Developments/Updates

6.9 NCPC

6.9.1 NCPC Corporation Information

6.9.2 NCPC Description and Business Overview

6.9.3 NCPC Gastric Antisecretory Drug Sales, Revenue and Gross Margin (2019-2024)

6.9.4 NCPC Gastric Antisecretory Drug Product Portfolio

6.9.5 NCPC Recent Developments/Updates

6.10 Luoxin

6.10.1 Luoxin Corporation Information

6.10.2 Luoxin Description and Business Overview

6.10.3 Luoxin Gastric Antisecretory Drug Sales, Revenue and Gross Margin (2019-2024)

6.10.4 Luoxin Gastric Antisecretory Drug Product Portfolio

6.10.5 Luoxin Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 Gastric Antisecretory Drug Industry Chain Analysis

7.2 Gastric Antisecretory Drug Key Raw Materials

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Gastric Antisecretory Drug Production Mode & Process

7.4 Gastric Antisecretory Drug Sales and Marketing

7.4.1 Gastric Antisecretory Drug Sales Channels

7.4.2 Gastric Antisecretory Drug Distributors

7.5 Gastric Antisecretory Drug Customers

8 Gastric Antisecretory Drug Market Dynamics

8.1 Gastric Antisecretory Drug Industry Trends

8.2 Gastric Antisecretory Drug Market Drivers

8.3 Gastric Antisecretory Drug Market Challenges

8.4 Gastric Antisecretory Drug Market Restraints

9 Research Finding and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

Bayer

Cadila Pharmaceuticals

List of Tables

Table 1. Global Gastric Antisecretory Drug Market Value Comparison by Type (2024-2030) & (US$ Million)

Table 2. Global Gastric Antisecretory Drug Market Value Comparison by Application (2024-2030) & (US$ Million)

Table 3. Global Gastric Antisecretory Drug Market Competitive Situation by Manufacturers in 2023

Table 4. Global Gastric Antisecretory Drug Sales (K Units) of Key Manufacturers (2019-2024)

Table 5. Global Gastric Antisecretory Drug Sales Market Share by Manufacturers (2019-2024)

Table 6. Global Gastric Antisecretory Drug Revenue (US$ Million) by Manufacturers (2019-2024)

Table 7. Global Gastric Antisecretory Drug Revenue Share by Manufacturers (2019-2024)

Table 8. Global Market Gastric Antisecretory Drug Average Price (US$/Unit) of Key Manufacturers (2019-2024)

Table 9. Global Key Players of Gastric Antisecretory Drug, Industry Ranking, 2022 VS 2023 VS 2024

Table 10. Global Key Manufacturers of Gastric Antisecretory Drug, Manufacturing Sites & Headquarters

Table 11. Global Key Manufacturers of Gastric Antisecretory Drug, Product Type & Application

Table 12. Global Key Manufacturers of Gastric Antisecretory Drug, Date of Enter into This Industry

Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Gastric Antisecretory Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gastric Antisecretory Drug as of 2023)

Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 16. Global Gastric Antisecretory Drug Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 17. Global Gastric Antisecretory Drug Sales by Region (2019-2024) & (K Units)

Table 18. Global Gastric Antisecretory Drug Sales Market Share by Region (2019-2024)

Table 19. Global Gastric Antisecretory Drug Sales by Region (2025-2030) & (K Units)

Table 20. Global Gastric Antisecretory Drug Sales Market Share by Region (2025-2030)

Table 21. Global Gastric Antisecretory Drug Revenue by Region (2019-2024) & (US$ Million)

Table 22. Global Gastric Antisecretory Drug Revenue Market Share by Region (2019-2024)

Table 23. Global Gastric Antisecretory Drug Revenue by Region (2025-2030) & (US$ Million)

Table 24. Global Gastric Antisecretory Drug Revenue Market Share by Region (2025-2030)

Table 25. North America Gastric Antisecretory Drug Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 26. North America Gastric Antisecretory Drug Sales by Country (2019-2024) & (K Units)

Table 27. North America Gastric Antisecretory Drug Sales by Country (2025-2030) & (K Units)

Table 28. North America Gastric Antisecretory Drug Revenue by Country (2019-2024) & (US$ Million)

Table 29. North America Gastric Antisecretory Drug Revenue by Country (2025-2030) & (US$ Million)

Table 30. Europe Gastric Antisecretory Drug Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 31. Europe Gastric Antisecretory Drug Sales by Country (2019-2024) & (K Units)

Table 32. Europe Gastric Antisecretory Drug Sales by Country (2025-2030) & (K Units)

Table 33. Europe Gastric Antisecretory Drug Revenue by Country (2019-2024) & (US$ Million)

Table 34. Europe Gastric Antisecretory Drug Revenue by Country (2025-2030) & (US$ Million)

Table 35. Asia Pacific Gastric Antisecretory Drug Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 36. Asia Pacific Gastric Antisecretory Drug Sales by Region (2019-2024) & (K Units)

Table 37. Asia Pacific Gastric Antisecretory Drug Sales by Region (2025-2030) & (K Units)

Table 38. Asia Pacific Gastric Antisecretory Drug Revenue by Region (2019-2024) & (US$ Million)

Table 39. Asia Pacific Gastric Antisecretory Drug Revenue by Region (2025-2030) & (US$ Million)

Table 40. Latin America Gastric Antisecretory Drug Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 41. Latin America Gastric Antisecretory Drug Sales by Country (2019-2024) & (K Units)

Table 42. Latin America Gastric Antisecretory Drug Sales by Country (2025-2030) & (K Units)

Table 43. Latin America Gastric Antisecretory Drug Revenue by Country (2019-2024) & (US$ Million)

Table 44. Latin America Gastric Antisecretory Drug Revenue by Country (2025-2030) & (US$ Million)

Table 45. Middle East & Africa Gastric Antisecretory Drug Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 46. Middle East & Africa Gastric Antisecretory Drug Sales by Country (2019-2024) & (K Units)

Table 47. Middle East & Africa Gastric Antisecretory Drug Sales by Country (2025-2030) & (K Units)

Table 48. Middle East & Africa Gastric Antisecretory Drug Revenue by Country (2019-2024) & (US$ Million)

Table 49. Middle East & Africa Gastric Antisecretory Drug Revenue by Country (2025-2030) & (US$ Million)

Table 50. Global Gastric Antisecretory Drug Sales (K Units) by Type (2019-2024)

Table 51. Global Gastric Antisecretory Drug Sales (K Units) by Type (2025-2030)

Table 52. Global Gastric Antisecretory Drug Sales Market Share by Type (2019-2024)

Table 53. Global Gastric Antisecretory Drug Sales Market Share by Type (2025-2030)

Table 54. Global Gastric Antisecretory Drug Revenue (US$ Million) by Type (2019-2024)

Table 55. Global Gastric Antisecretory Drug Revenue (US$ Million) by Type (2025-2030)

Table 56. Global Gastric Antisecretory Drug Revenue Market Share by Type (2019-2024)

Table 57. Global Gastric Antisecretory Drug Revenue Market Share by Type (2025-2030)

Table 58. Global Gastric Antisecretory Drug Price (US$/Unit) by Type (2019-2024)

Table 59. Global Gastric Antisecretory Drug Price (US$/Unit) by Type (2025-2030)

Table 60. Global Gastric Antisecretory Drug Sales (K Units) by Application (2019-2024)

Table 61. Global Gastric Antisecretory Drug Sales (K Units) by Application (2025-2030)

Table 62. Global Gastric Antisecretory Drug Sales Market Share by Application (2019-2024)

Table 63. Global Gastric Antisecretory Drug Sales Market Share by Application (2025-2030)

Table 64. Global Gastric Antisecretory Drug Revenue (US$ Million) by Application (2019-2024)

Table 65. Global Gastric Antisecretory Drug Revenue (US$ Million) by Application (2025-2030)

Table 66. Global Gastric Antisecretory Drug Revenue Market Share by Application (2019-2024)

Table 67. Global Gastric Antisecretory Drug Revenue Market Share by Application (2025-2030)

Table 68. Global Gastric Antisecretory Drug Price (US$/Unit) by Application (2019-2024)

Table 69. Global Gastric Antisecretory Drug Price (US$/Unit) by Application (2025-2030)

Table 70. Bayer Corporation Information

Table 71. Bayer Description and Business Overview

Table 72. Bayer Gastric Antisecretory Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 73. Bayer Gastric Antisecretory Drug Product

Table 74. Bayer Recent Developments/Updates

Table 75. Cadila Pharmaceuticals Corporation Information

Table 76. Cadila Pharmaceuticals Description and Business Overview

Table 77. Cadila Pharmaceuticals Gastric Antisecretory Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 78. Cadila Pharmaceuticals Gastric Antisecretory Drug Product

Table 79. Cadila Pharmaceuticals Recent Developments/Updates

Table 80. AstraZeneca Corporation Information

Table 81. AstraZeneca Description and Business Overview

Table 82. AstraZeneca Gastric Antisecretory Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 83. AstraZeneca Gastric Antisecretory Drug Product

Table 84. AstraZeneca Recent Developments/Updates

Table 85. Jiangsu Aosaikang Corporation Information

Table 86. Jiangsu Aosaikang Description and Business Overview

Table 87. Jiangsu Aosaikang Gastric Antisecretory Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 88. Jiangsu Aosaikang Gastric Antisecretory Drug Product

Table 89. Jiangsu Aosaikang Recent Developments/Updates

Table 90. Eisai Corporation Information

Table 91. Eisai Description and Business Overview

Table 92. Eisai Gastric Antisecretory Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 93. Eisai Gastric Antisecretory Drug Product

Table 94. Eisai Recent Developments/Updates

Table 95. Pfizer Corporation Information

Table 96. Pfizer Description and Business Overview

Table 97. Pfizer Gastric Antisecretory Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 98. Pfizer Gastric Antisecretory Drug Product

Table 99. Pfizer Recent Developments/Updates

Table 100. Altana Pharma Corporation Information

Table 101. Altana Pharma Description and Business Overview

Table 102. Altana Pharma Gastric Antisecretory Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 103. Altana Pharma Gastric Antisecretory Drug Product

Table 104. Altana Pharma Recent Developments/Updates

Table 105. Takeda Corporation Information

Table 106. Takeda Description and Business Overview

Table 107. Takeda Gastric Antisecretory Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 108. Takeda Gastric Antisecretory Drug Product

Table 109. Takeda Recent Developments/Updates

Table 110. NCPC Corporation Information

Table 111. NCPC Description and Business Overview

Table 112. NCPC Gastric Antisecretory Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 113. NCPC Gastric Antisecretory Drug Product

Table 114. NCPC Recent Developments/Updates

Table 115. Luoxin Corporation Information

Table 116. Luoxin Description and Business Overview

Table 117. Luoxin Gastric Antisecretory Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 118. Luoxin Gastric Antisecretory Drug Product

Table 119. Luoxin Recent Developments/Updates

Table 120. Key Raw Materials Lists

Table 121. Raw Materials Key Suppliers Lists

Table 122. Gastric Antisecretory Drug Distributors List

Table 123. Gastric Antisecretory Drug Customers List

Table 124. Gastric Antisecretory Drug Market Trends

Table 125. Gastric Antisecretory Drug Market Drivers

Table 126. Gastric Antisecretory Drug Market Challenges

Table 127. Gastric Antisecretory Drug Market Restraints

Table 128. Research Programs/Design for This Report

Table 129. Key Data Information from Secondary Sources

Table 130. Key Data Information from Primary Sources

List of Figures

Figure 1. Product Picture of Gastric Antisecretory Drug

Figure 2. Global Gastric Antisecretory Drug Market Value Comparison by Type (2024-2030) & (US$ Million)

Figure 3. Global Gastric Antisecretory Drug Market Share by Type in 2023 & 2030

Figure 4. H2-receptor Antagonists Product Picture

Figure 5. Gastric Proton Pump Inhibitors Product Picture

Figure 6. Others Product Picture

Figure 7. Global Gastric Antisecretory Drug Market Value Comparison by Application (2024-2030) & (US$ Million)

Figure 8. Global Gastric Antisecretory Drug Market Share by Application in 2023 & 2030

Figure 9. Dyspepsia

Figure 10. Peptic Ulcer

Figure 11. Gastroesophageal Reflux

Figure 12. Others

Figure 13. Global Gastric Antisecretory Drug Revenue, (US$ Million), 2019 VS 2023 VS 2030

Figure 14. Global Gastric Antisecretory Drug Market Size (2019-2030) & (US$ Million)

Figure 15. Global Gastric Antisecretory Drug Sales (2019-2030) & (K Units)

Figure 16. Global Gastric Antisecretory Drug Average Price (US$/Unit) & (2019-2030)

Figure 17. Gastric Antisecretory Drug Report Years Considered

Figure 18. Gastric Antisecretory Drug Sales Share by Manufacturers in 2023

Figure 19. Global Gastric Antisecretory Drug Revenue Share by Manufacturers in 2023

Figure 20. The Global 5 and 10 Largest Gastric Antisecretory Drug Players: Market Share by Revenue in 2023

Figure 21. Gastric Antisecretory Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023

Figure 22. Global Gastric Antisecretory Drug Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Figure 23. North America Gastric Antisecretory Drug Sales Market Share by Country (2019-2030)

Figure 24. North America Gastric Antisecretory Drug Revenue Market Share by Country (2019-2030)

Figure 25. U.S. Gastric Antisecretory Drug Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 26. Canada Gastric Antisecretory Drug Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 27. Europe Gastric Antisecretory Drug Sales Market Share by Country (2019-2030)

Figure 28. Europe Gastric Antisecretory Drug Revenue Market Share by Country (2019-2030)

Figure 29. Germany Gastric Antisecretory Drug Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 30. France Gastric Antisecretory Drug Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 31. U.K. Gastric Antisecretory Drug Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 32. Italy Gastric Antisecretory Drug Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 33. Russia Gastric Antisecretory Drug Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 34. Asia Pacific Gastric Antisecretory Drug Sales Market Share by Region (2019-2030)

Figure 35. Asia Pacific Gastric Antisecretory Drug Revenue Market Share by Region (2019-2030)

Figure 36. China Gastric Antisecretory Drug Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 37. Japan Gastric Antisecretory Drug Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 38. South Korea Gastric Antisecretory Drug Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 39. India Gastric Antisecretory Drug Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 40. Australia Gastric Antisecretory Drug Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 41. Taiwan Gastric Antisecretory Drug Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 42. Indonesia Gastric Antisecretory Drug Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 43. Thailand Gastric Antisecretory Drug Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 44. Malaysia Gastric Antisecretory Drug Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 45. Philippines Gastric Antisecretory Drug Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 46. Latin America Gastric Antisecretory Drug Sales Market Share by Country (2019-2030)

Figure 47. Latin America Gastric Antisecretory Drug Revenue Market Share by Country (2019-2030)

Figure 48. Mexico Gastric Antisecretory Drug Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 49. Brazil Gastric Antisecretory Drug Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 50. Argentina Gastric Antisecretory Drug Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 51. Middle East & Africa Gastric Antisecretory Drug Sales Market Share by Country (2019-2030)

Figure 52. Middle East & Africa Gastric Antisecretory Drug Revenue Market Share by Country (2019-2030)

Figure 53. Turkey Gastric Antisecretory Drug Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 54. Saudi Arabia Gastric Antisecretory Drug Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 55. UAE Gastric Antisecretory Drug Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 56. Global Sales Market Share of Gastric Antisecretory Drug by Type (2019-2030)

Figure 57. Global Revenue Market Share of Gastric Antisecretory Drug by Type (2019-2030)

Figure 58. Global Gastric Antisecretory Drug Price (US$/Unit) by Type (2019-2030)

Figure 59. Global Sales Market Share of Gastric Antisecretory Drug by Application (2019-2030)

Figure 60. Global Revenue Market Share of Gastric Antisecretory Drug by Application (2019-2030)

Figure 61. Global Gastric Antisecretory Drug Price (US$/Unit) by Application (2019-2030)

Figure 62. Gastric Antisecretory Drug Value Chain

Figure 63. Gastric Antisecretory Drug Production Process

Figure 64. Channels of Distribution (Direct Vs Distribution)

Figure 65. Distributors Profiles

Figure 66. Bottom-up and Top-down Approaches for This Report

Figure 67. Data Triangulation

Figure 68. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions